|
|
楼主 |
发表于 2025-2-6 15:36:45
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-2-6 16:03 编辑 6 c' X: I& P+ o
0 d0 T. i9 }. C/ a! i今年的ISC大会Late-Breaking Science（重磅研究）已经出炉，国内单位入选情况
5 f6 ]# @" N3 V6 @0 h y4 k9 N
! L; e& f0 ~; T0 G- TLB2. TransRadial versus transfemoral Arterial access for CErebral angiography3 W8 {& s! ~. ?( [: j) x
Wei Ni, Huashan Hospital, Fudan University, Shanghai, China
! K' \/ m- w2 A
/ M- P: E( e! C* n* d1 t/ aLB17. Intensive Blood Pressure Lowering After Thrombectomy in Ischemic Stroke Patients-A Randomized Clinical Trial7 |7 y- v8 _& M' B1 f
Xuening Zhang, West China Hospital, Sichuan University, Chendu, China
/ p- E- U, W2 d7 b# t8 |" g. u3 V; a
LB38. Intra-arterial Tenecteplase thrombolysis for acute LVO after successful mechanical thrombectomy recanalization (ANGEL-TNK) — A Multicenter, Prospective, Randomized, Open-label, Blinded End-point Trial
% e% f% x; f* |0 p6 Y/ d+ {8 VMiao Zhongrong, Beijing Tiantan Hospital, Beijing, China9 i2 ]' Y: u4 p9 N' n7 X
! h4 C+ g" D; b# B4 |+ T
LB39. The Optimal Dosage of ADjunctive Intra-Arterial Tenecteplase following Successful Endovascular Thrombectomy in Patients with Large Vessel Occlusion Acute Ischemic Stroke (DATE) Trail
h1 ~6 K0 X( |$ J$ R: uXianhua Hou, The First Affiliated Hospital, Army Medical University, Chongqing, China& M2 n# y l" K& [2 ?+ o
+ v( w4 \0 Y9 e6 G; LLB41. Treatment with intravenous alteplase in ischemic stroke patients with onset time between 4.5 and 24 hours- G; ]8 g; W) q9 L7 K
Min Lou, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China( d( t& `4 v1 _. Z3 s" G0 ?) E
) X: l+ I2 f- k$ ^8 pLB42. Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy (PEARL): A Multicenter Randomized Trial' g" Q4 z3 Q1 J% g" H, k9 d' p
Yamei Tang, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China% @( X* }7 `% Q/ _
; @: |/ v5 ?/ D8 p
LB44. Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients with Type 2 Diabetes Mellitus (LAMP): A Randomized Clinical Trial$ S. F [% h6 _+ D
Huili Zhu, The First Affiliated Hospital of Jinan University, Guangzhou, China
9 s/ c+ ?) Y7 _! V: L) N5 Z1 U. n+ O9 b
LB45. BXOS110 for Acute Ischemic Stroke Treatment (BEST): A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial+ E# I" V% F( G1 v& F* l7 w
Yarong Ding, Beijing Tiantan Hospital, Beijing, China' [1 A6 E; [- C' a5 @2 Z
5 Q+ W4 f6 e# n% N
祝贺以上单位！# t x3 c. \, d- J4 h1 v
|
|
发表于 2025-2-6 15:11:41
发表于 2025-2-6 15:40:38
